US equities have now erased almost 90% of their losses seen in the aftermath of 'Liberation Day'. The mood music on trade has improved slightly, and a US-Ukraine minerals deal helps, too.
With no data in, the GDPNow model starts off the second quarter with a nowcast of 2.4 percent. A deeper dive into the model data has Real Final Sales at 2.6 percent to start the quarter.
Needham called the tie-up a “groundbreaking partnership” and said it alleviates investor concerns around Hims’ ability to hit its 2025 weight loss revenue guidance.
Nearly two years after its launch, World (CRYPTO: WLD), co-founded by OpenAI CEO Sam Altman, debuted in the U.S. on Thursday. The decentralized identity verification project also unveiled a new smartphone-like device for identity verification and a debit card to make WLD payments.
Silver (XAG/USD) drifts lower for the third straight day – also marking the fourth day of a negative move in the previous five – and drops to over a two-week low during the Asian session on Thursday.
Regulus Therapeutics shares surged after Novartis announced a $1.7 billion acquisition, but analysts downgraded the stock citing limited upside. Retail sentiment remained bullish, with speculation of a higher bid or FDA-driven gains.
Microsoft plans to leverage its cloud services and customer-centric solutions to not only survive a recession but also grow by helping businesses manage economic challenges.
CFO Amy Hood said that through April, demand signals across its commercial businesses, as well as on LinkedIn, Gaming, and Search, remained consistent.
Petros Pharmaceuticals hit an all-time low after a 1-for-25 reverse stock split, drawing bullish retail chatter even as delisting risks and mounting losses weighed on the stock.
Over the past six months, ICU Medical’s shares (currently trading at $140.27) have posted a disappointing 17.9% loss while the S&P 500 was down 2.9%. This may have investors wondering how to approach the situation.
Hertz has been on fire lately. In the past six months alone, the company’s stock price has rocketed 144%, reaching $6.80 per share. This run-up might have investors contemplating their next move.
